AzTrials
AzTrials

Surgical EducationOpVerseNCT06524297

The Training of Resident Surgeons in Single-Port Thoracoscopic Surgery Wound Position Selection

A study testing Metaverse system (Patients) and Metaverse system (Resident Physician) in people with Surgical Education, run by National Taiwan University Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

the metaverse system applied to the training of wound location selection for singleport thoracoscopic surgery. The experimental design is two groups of 40 computer tomography located superficially less than 2 cm lung nodule patients, one group uses the metaverse system to let resident physicians simulate the wound… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Surgical Education
What is being tested?
Metaverse system (Patients) and Metaverse system (Resident Physician)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
No sites listed yet
Study dates
15 Aug 2025to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged 18 years or older.
  • Diagnosed with a lung nodule no larger than 2cm in diameter. The lesion depth must be located within the outer third of the lung.
  • Scheduled to undergo computer tomography-guided single-port thoracoscopic wedge resection at National Taiwan University Hospital (NTUH) or National Taiwan Cancer Center (NTUCC).
  • Participants who have provided written informed consent for their imaging data to be used by the team to create digital twin models.
  • Third-year to fifth-year residents in the Department of Thoracic Surgery at National Taiwan University Hospital.

Who cannot join

  • Patients with lesions larger than 2 cm.
  • Patients not planned for single-port thoracoscopic wedge resection with computed tomography localization.
  • Patients who have not provided written consent.
  • Members of vulnerable populations.
  • Residents who are unwilling to participate in the study and decline to sign the consent form.
  • Residents with a history of cybersickness.

Trial locations and contacts

No sites are listed yet.

Chiang contact

About this study

Official title: The Role of a Metaverse Surgical Simulation System in Guiding Incision Site Selection for Uniportal Video-Assisted Thoracoscopic Surgery

the metaverse system applied to the training of wound location selection for singleport thoracoscopic surgery. The experimental design is two groups of 40 computer tomography located superficially less than 2 cm lung nodule patients, one group uses the metaverse system to let resident physicians simulate the wound position on the digital twin organs of each patient, and the other group does not use it. The investigators will evaluate the surgeon's satisfaction with the surgical wound position and urgicalrelated results (such as surgery time, blood loss, etc.). The investigators expect that the system will help improve the appropriateness of resident physicians' choice of wound location for high-difficulty single-port thoracoscopic surgery, help them cross the first threshold necessary to familiarize themselves with the surgery faster, and accelerate learning.

Read the detailed description

The evolution of single-port thoracoscopic surgery, due to advancements in instrumentation and video technology, has seen a leap in progress since the 2010s.

Today, single-port thoracoscopic surgery has become the mainstream at NTU Thoracic Surgery, capable of performing simple wedge resections or complex pneumonectomies. Single-port thoracoscopic surgery, using only a single wound, aids patients in quickly regaining their preoperative normal life functions, with further reductions in pain. However, its learning curve is steep, with the appropriate choice of wound location being one of the most important thresholds for resident physicians to master this technique. Currently, NTU Surgery and the Media Lab have jointly developed a metaverse surgical simulation platform (OpVerse), creating digital twin organ models through 3D reconstruction software and modeling engines. In mixed reality, including lesion location and anatomical variations, are no different from specific real patients. Users can view and operate CT images and 3D models arbitrarily, mark important structural positions and directions, and measure distances with an XR helmet. The model can also be cross-referenced with CT through cross-sectional positioning. The investigators set up a thoracoscopic simulation lens in the system, superimposing the digital twin model on the patient on the operating table, and using the CT cross-section comparison function in the metaverse system to find the lesion location, resident physicians can repeatedly simulate the wound position through the system, and mark the expected entry wound position on the patient through virtual reality overlay. This project plans to conduct a randomized trial to explore the effectiveness of the metaverse system applied to the training of wound location selection for singleport thoracoscopic surgery. The experimental design is two groups of 40 computer tomography located superficially less than 2 cm lung nodule patients, one group uses the metaverse system to let resident physicians simulate the wound position on the digital twin organs of each patient, and the other group does not use it. The investigators will evaluate the surgeon's satisfaction with the surgical wound position and surgical related results (such as surgery time, blood loss, etc.).

The investigators expect that the system will help improve the appropriateness of resident physicians' choice of wound location for high-difficulty single-port thoracoscopic surgery, help them cross the first threshold necessary to familiarize themselves with the surgery faster, and accelerate learning.

Being tested
Metaverse system (Patients), Metaverse system (Resident Physician)
Keywords
Metaverse, Surgical Education, Surgical Simulation, Digital Twin, Mixed Reality, Single-Port Thoracoscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Metaverse system (Patients)Other

    The experimental group will undergo preoperative training using the metaverse surgical simulation system for 15 minutes before selecting the surgical incision site (this refers to residents receiving the assisted training). The trial process requires participants' consent to provide high-resolution CT images as the basis for reconstructing digital twin organs. Except for the intervention training, the surgery, postoperative care, follow-up, and other treatment processes the participants receive will be the same as those for typical patients.

  • Metaverse system (Resident Physician)Other

    The participants (residents) will receive 15 minutes of preoperative training using the Metaverse surgical simulation system. They will superimpose the digital twin model onto the patient on the operating table and use the CT cross-sectional matching function within the Metaverse system to locate the lesion. The participants (residents) can use the system to repeatedly simulate incision sites and mark planned entry points on the patient by overlaying the virtual model onto the real patient. Except for the intervention training with the system, the subsequent surgery, postoperative care, follow-up, and other treatment processes the patients receive will be the same as usual.

Study groups in NCT06524297
Study groupRoleWhat they receive
Metaverse systemExperimentalResidents use the Metaverse system before surgery to simulate wound closure locations on digital twin organs of the patient.
Receives: Other: Metaverse system (Patients); Other: Metaverse system (Resident Physician)
Crontrol groupNo interventionThe control group do not use the Metaverse system.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Operation time

    Compare the length of operation time between the experimental group (trained using the Metaverse surgical simulation system for 15 minutes pre-operatively) and the control group. This analysis will assess whether pre-operative simulation training reduces operation time for residents.

    Measured: 24 hours

Secondary outcomes (1)
  1. Satisfaction Questionnaire for Attending Physicians

    To improve the residents selection of wound locations during single-port thoracoscopic surgery, the attending physician will complete a post-operative questionnaire regarding the residents' pre-operative simulation training.

    Measured: Through study completion, an average of 1 year.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jul 2024
  2. Study start15 Aug 2025 (estimated)
  3. Primary completion30 Nov 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06524297
Sponsor's protocol ID
202407156RINB
Acronym
OpVerse
Status last verified
Jul 2024
First submitted
23 Jul 2024
Last updated
14 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Metaverse system (Patients) and Metaverse system (Resident Physician) in people with Surgical Education, run by National Taiwan University Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 May 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Chiang (+886972655136, lycansblueray@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Operation time (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in